GT BIOPHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $-29.6M | $855.0K |
| FY2015 | — | $-50.6M | $47.0K |
| FY2016 | — | $-18.9M | $19.0K |
| FY2017 | — | $251.7M | $576.0K |
| FY2018 | — | $11.4M | $60.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $-29.6M | $855.0K |
| FY2015 | — | $-50.6M | $47.0K |
| FY2016 | — | $-18.9M | $19.0K |
| FY2017 | — | $251.7M | $576.0K |
| FY2018 | — | $11.4M | $60.0K |